22855-54-5

Upstream product

• 20608-82-6 2-(2-bromophenyl)succinic acid 

Downstream Products

• 1349403-15-1 1-[(morpholin-4-yl)-methyl]-3-(2-bromophenyl)-pyrrolidine-2,5-dione 
• 1392655-22-9 1-[(4-cyclohexylpiperazin-1-yl)-methyl]-3-(2-bromophenyl)-pyrrolidine-2,5-dione 
• 1392654-53-3 1-[(4-phenylpiperazin-1-yl)-methyl]-3-(2-bromophenyl)-pyrrolidine-2,5-dione 
• 1392654-77-1 1-[{4-(4-chlorophenyl)-piperazin-1-yl}-methyl]-3-(2-bromophenyl)-pyrrolidine-2,5-dione 
• 1392655-17-2 1-[{4-(pyrimid-2-yl)-piperazin-1-yl}-methyl]-3-(2-bromophenyl)-pyrrolidine-2,5-dione 
• 1392654-66-8 1-[{4-(2-chlorophenyl)-piperazin-1-yl}-methyl]-3-(2-bromophenyl)-pyrrolidine-2,5-dione 
• 1392654-61-3 1-[{4-(4-fluorophenyl)-piperazin-1-yl}-methyl]-3-(2-bromophenyl)-pyrrolidine-2,5-dione 
• 1392654-58-8 1-[{4-(2-fluorophenyl)-piperazin-1-yl}-methyl]-3-(2-bromophenyl)-pyrrolidine-2,5-dione 
• 1392654-82-8 1-[{4-(3-trifluoromethylphenyl)-piperazin-1-yl}-methyl]-3-(2-bromophenyl)-pyrrolidine-2,5-dione 
• 1392654-72-6 1-[{4-(3-chlorophenyl)-piperazin-1-yl}-methyl]-3-(2-bromophenyl)-pyrrolidine-2,5-dione 

Relevant academic research and scientific papers

Synthesis and anticonvulsant activity of new N-Mannich bases derived from 3-(2-fluorophenyl)- and 3-(2-bromophenyl)-pyrrolidine-2,5-diones. Part II

Synthesis and anticonvulsant activity of new N-Mannich bases of 3-(2-fluorophenyl)- and 3-(2-bromophenyl)-pyrrolidine-2,5-diones have been described. Initial anticonvulsant screening was performed in mice after intraperitoneal administration in the maxima